← All trials
NCT05098249
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 11, 2021
- Primary completion
- Oct 17, 2023
- Completion date
- Oct 17, 2024
- First posted
- Oct 28, 2021
- Last posted
- Nov 22, 2021
- Enrollment
- 188
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of ZurichLead sponsor
- University of ZurichSponsor investigator
- University of ZurichOverall official - principal investigator
- University of ZurichCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.